Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2025 Earnings Call Transcript November 4, 2025
Ocular Therapeutix, Inc. beats earnings expectations. Reported EPS is $-0.37744, expectations were $-0.39.
Operator: Good morning, and welcome to the Ocular Therapeutix Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded and will be available for replay on the Investor Relations section of the Ocular Therapeutix website. I would now like...
